Works matching IS 21986576 AND DT 2024 AND VI 11 AND IP 3
Results: 24
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 737, doi. 10.1007/s40744-024-00671-4
- By:
- Publication type:
- Article
A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 755, doi. 10.1007/s40744-024-00670-5
- By:
- Publication type:
- Article
Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 869, doi. 10.1007/s40744-024-00669-y
- By:
- Publication type:
- Article
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 709, doi. 10.1007/s40744-024-00668-z
- By:
- Publication type:
- Article
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 663, doi. 10.1007/s40744-024-00667-0
- By:
- Publication type:
- Article
Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 675, doi. 10.1007/s40744-024-00666-1
- By:
- Publication type:
- Article
Current Use and Barriers to Point-of-Care Ultrasound in Rheumatology: A National Survey of VA Medical Centers.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 855, doi. 10.1007/s40744-024-00665-2
- By:
- Publication type:
- Article
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 795, doi. 10.1007/s40744-024-00664-3
- By:
- Publication type:
- Article
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: 'Calls to Action' from Rheumacensus, a Multistakeholder Pan-European Initiative.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 773, doi. 10.1007/s40744-024-00663-4
- By:
- Publication type:
- Article
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 487, doi. 10.1007/s40744-024-00662-5
- By:
- Publication type:
- Article
Long-Term Efficacy Following Intra-articular Injection of Carboxymethyl-chitosan, a New Product Class for Knee Osteoarthritis: Results from an Observational Study in Germany.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 649, doi. 10.1007/s40744-024-00661-6
- By:
- Publication type:
- Article
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 691, doi. 10.1007/s40744-024-00660-7
- By:
- Publication type:
- Article
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 829, doi. 10.1007/s40744-024-00659-0
- By:
- Publication type:
- Article
Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 599, doi. 10.1007/s40744-024-00658-1
- By:
- Publication type:
- Article
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 633, doi. 10.1007/s40744-024-00657-2
- By:
- Publication type:
- Article
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 583, doi. 10.1007/s40744-024-00656-3
- By:
- Publication type:
- Article
Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 553, doi. 10.1007/s40744-024-00655-4
- By:
- Publication type:
- Article
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 617, doi. 10.1007/s40744-024-00654-5
- By:
- Publication type:
- Article
Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 841, doi. 10.1007/s40744-024-00653-6
- By:
- Publication type:
- Article
Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 817, doi. 10.1007/s40744-024-00652-7
- By:
- Publication type:
- Article
Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 563, doi. 10.1007/s40744-024-00651-8
- By:
- Publication type:
- Article
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 501, doi. 10.1007/s40744-024-00650-9
- By:
- Publication type:
- Article
The Evaluation of Effectiveness and Safety of Guselkumab in Patients with Psoriatic Arthritis in a Prospective Multicentre "Real-Life" Cohort Study.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 539, doi. 10.1007/s40744-024-00649-2
- By:
- Publication type:
- Article
Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 523, doi. 10.1007/s40744-024-00647-4
- By:
- Publication type:
- Article